Table 1.
Summary of Known Resistance Mechanisms to Checkpoint Inhibitors
| Categories of Resistance | Mechanism of Resistance |
|---|---|
| Tumor intrinsic factors | Downregulation of antigen processing and presentation: HLA deletion144,145, β2 microglobulin146 |
| Downregulation of cytokines and signaling pathways: loss of JAK1/2 function69,147, deletion of interferon IFNGR1/2, IRF1 148 | |
| β-Catenin activation (due to mutations in CTNNB1 gene)73 | |
| Tumor extrinsic factors | TILs exclusion by PTEN deletion and VEGF upregulation149 |
| Expression of alternative coinhibitory checkpoint receptors like TIM-3, LAG-3, TIGIT, VISTA, and BTLA69,126 | |
| Decreased TILs to Treg ratio150–152 | |
| Downregulation of dendritic cell recruitment through β-catenin signaling110 | |
| Increased immunosuppressive cells such as MDSCs, Tregs151,153,154 | |
| Epithelial-to-mesenchymal transition155 | |
| Microbiome75, 143 |